Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma

BACKGROUND: Pancreatic cancer has a 5-year survival rate of only 5–7%. Difficulties in detecting pancreatic cancer at early stages results in the high mortality and substantiates the need for additional diagnostic tools. Surgery is the only curative treatment and unfortunately only possible in local...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Epigenetics
Main Authors: Henriksen, Stine Dam, Madsen, Poul Henning, Larsen, Anders Christian, Johansen, Martin Berg, Drewes, Asbjørn Mohr, Pedersen, Inge Søkilde, Krarup, Henrik, Thorlacius-Ussing, Ole
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112622/
https://ncbi.nlm.nih.gov/pubmed/27891190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-016-0286-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki